Galderma Group AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 22, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	42,364	26,384	-	-	-
Enterprise Value	44,759	28,925	-	-	-
Last Close Price	36.17	22.43	-	-	-
PE Ratio	112.07	114.22	-	-	-
PS Ratio	9.03	5.94	-	-	-
PB Ratio	5.48	3.39	-	-	-
P/FCF Ratio	50.19	73.29	-	-	-
P/OCF Ratio	44.55	54.07	-	-	-
EV/Sales Ratio	9.52	6.52	-	-	-
EV/EBITDA Ratio	44.09	32.46	-	-	-
EV/EBIT Ratio	60.11	43.11	-	-	-
EV/FCF Ratio	53.03	80.35	-	-	-
Debt / Equity Ratio	0.37	0.35	0.91	1.27	1.25
Debt / EBITDA Ratio	2.81	3.00	5.83	8.68	9.67
Debt / FCF Ratio	3.37	7.66	111.57	583.27	39.02
Asset Turnover	0.37	0.35	0.33	0.31	-
Inventory Turnover	3.15	3.29	2.86	3.03	-
Quick Ratio	0.76	0.89	0.72	0.52	0.55
Current Ratio	1.09	1.21	1.03	0.77	0.82
Return on Equity (ROE)	4.92%	3.51%	-1.16%	-2.15%	-
Return on Assets (ROA)	3.65%	3.34%	3.04%	2.01%	-
Return on Capital (ROIC)	4.39%	4.03%	3.71%	2.46%	-
Return on Capital Employed (ROCE)	6.70%	6.10%	5.60%	3.80%	3.30%
Earnings Yield	0.89%	0.88%	-	-	-
FCF Yield	1.99%	1.36%	-	-	-
Buyback Yield / Dilution	-0.11%	-0.10%	95.42%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.